Results 161 to 170 of about 68,915 (226)

Phase II study of FOLFIRI with low-dose irinotecan plus ramucirumab as second-line treatment in Japanese patients with metastatic colorectal cancer (study rindo). [PDF]

open access: yesJpn J Clin Oncol
Hattori N   +14 more
europepmc   +1 more source

Assessment of identified RDI initiatives

open access: yes
Full assessment of drivers, barriers, funding mechanisms, typical RDI initiatives, etc.
openaire   +1 more source

Portfolio of RDI Initiatives (V3)

open access: yes
Descripts of RDI Initiatives contributing to ...
openaire   +1 more source

DAREnet Challenges and RDI Topics

open access: yes
Report on the identified challenges and RDI toprics, including a short rationale; contributing to D8.3.
openaire   +1 more source

Home - About - Disclaimer - Privacy